No recent analyst price targets found for SVA.
Latest News for SVA
SINOVAC Announces Nasdaq Hearings Panel Grants Continued Listing
BEIJING--(BUSINESS WIRE)--Sinovac Biotech Ltd. (Nasdaq: SVA) (“SINOVAC” or the “Company”), a leading provider of biopharmaceutical products in China, today announced that the Nasdaq Hearings Panel (the “Panel”) has granted the Company's request to continue its listing on the Nasdaq Stock Market, subject to stated conditions focused on timely completion of its financial audit and remediation of filing delinquencies.…
🧮 Earnings Move Analyzer
Insider Trading
Insider Trading
| Name | Role | Date | Type | Shares | Price | Form | Link |
|---|
Senate Trading
No Senate trades found for SVA.
U.S. House Trading
No House trades found for SVA.
Options Chain
Select an expiration to expand. Bid/Ask are shown first (before Mark) on both sides.